Aug 30, 2023
In this episode, we delve into a new horizon in the management
of acute agitation. We discuss dexmedetomidine, a drug that's been
around since 1999, recently reformulated into a sublingual film and
FDA approved for treating agitation associated with schizophrenia
or bipolar I or II disorder. We explore the results from a recent
randomized trial and its potential for transforming psychiatric
Faculty: Jim Phelps, M.D.
Host: Richard Seeber, M.D.